These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Early Effect of Supplemented Infant Formulae on Intestinal Biomarkers and Microbiota: A Randomized Clinical Trial. Castanet M, Costalos C, Haiden N, Hascoet JM, Berger B, Sprenger N, Grathwohl D, Brüssow H, De Groot N, Steenhout P, Pecquet S, Benyacoub J, Picaud JC. Nutrients; 2020 May 20; 12(5):. PubMed ID: 32443684 [Abstract] [Full Text] [Related]
25. Effect of formula composition on the development of infant gut microbiota. Hascoët JM, Hubert C, Rochat F, Legagneur H, Gaga S, Emady-Azar S, Steenhout PG. J Pediatr Gastroenterol Nutr; 2011 Jun 20; 52(6):756-62. PubMed ID: 21593648 [Abstract] [Full Text] [Related]
28. Safety and efficacy of a probiotic-containing infant formula supplemented with 2'-fucosyllactose: a double-blind randomized controlled trial. Alliet P, Vandenplas Y, Roggero P, Jespers SNJ, Peeters S, Stalens JP, Kortman GAM, Amico M, Berger B, Sprenger N, Cercamondi CI, Corsello G. Nutr J; 2022 Feb 22; 21(1):11. PubMed ID: 35193609 [Abstract] [Full Text] [Related]
29. Targeting the gut-lung axis by synbiotic feeding to infants in a randomized controlled trial. Sjödin KS, Sjödin A, Ruszczyński M, Kristensen MB, Hernell O, Szajewska H, West CE. BMC Biol; 2023 Feb 20; 21(1):38. PubMed ID: 36803508 [Abstract] [Full Text] [Related]
32. Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants. Korpela K, Salonen A, Vepsäläinen O, Suomalainen M, Kolmeder C, Varjosalo M, Miettinen S, Kukkonen K, Savilahti E, Kuitunen M, de Vos WM. Microbiome; 2018 Oct 16; 6(1):182. PubMed ID: 30326954 [Abstract] [Full Text] [Related]
36. A combination of scGOS/lcFOS with Bifidobacterium breve M-16V protects suckling rats from rotavirus gastroenteritis. Rigo-Adrover M, Saldaña-Ruíz S, van Limpt K, Knipping K, Garssen J, Knol J, Franch A, Castell M, Pérez-Cano FJ. Eur J Nutr; 2017 Jun 16; 56(4):1657-1670. PubMed ID: 27112962 [Abstract] [Full Text] [Related]
37. Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial. Smilowitz JT, Moya J, Breck MA, Cook C, Fineberg A, Angkustsiri K, Underwood MA. BMC Pediatr; 2017 May 30; 17(1):133. PubMed ID: 28558732 [Abstract] [Full Text] [Related]
38. Infant Formula With a Specific Blend of Five Human Milk Oligosaccharides Drives the Gut Microbiota Development and Improves Gut Maturation Markers: A Randomized Controlled Trial. Bosheva M, Tokodi I, Krasnow A, Pedersen HK, Lukjancenko O, Eklund AC, Grathwohl D, Sprenger N, Berger B, Cercamondi CI, 5 HMO Study Investigator Consortium. Front Nutr; 2022 May 30; 9():920362. PubMed ID: 35873420 [Abstract] [Full Text] [Related]
39. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial. Bogovič Matijašić B, Obermajer T, Lipoglavšek L, Sernel T, Locatelli I, Kos M, Šmid A, Rogelj I. J Dairy Sci; 2016 Jul 30; 99(7):5008-5021. PubMed ID: 27157575 [Abstract] [Full Text] [Related]
40. Safety and efficacy of inulin and oligofructose supplementation in infant formula: results from a randomized clinical trial. Closa-Monasterolo R, Gispert-Llaurado M, Luque V, Ferre N, Rubio-Torrents C, Zaragoza-Jordana M, Escribano J. Clin Nutr; 2013 Dec 30; 32(6):918-27. PubMed ID: 23498848 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]